Inventor · disambiguated record
Brian C. Austad
Also filed as: AUSTAD BRIAN · AUSTAD BRIAN C
31 granted patents·4 pending applications·474 citations·filing 2005–2023
97Inventor score
Files withINFINITY PHARMACEUTICALS INC11KARYOPHARM THERAPEUTICS INC8AUSTAD BRIAN5AUSTAD BRIAN C5EISAI R&D MAN CO LTD3
Top patents by PatentIndex Score
35 records- 0199US7982060B2Intermediates for the preparation of analogs of Halichondrin BEISAI R&D MAN CO LTD·Filed 2005·Granted Jul 19, 2011·80 cites·18 claims
- 0299US7812164B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·84 cites·2 claims
- 0398US11807629B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·6 cites·7 claims
- 0498US11753401B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 12, 2023·5 cites·23 claims
- 0598US11746102B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 5, 2023·5 cites·17 claims
- 0697US11078190B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·11 cites·20 claims
- 0797US10519139B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 31, 2019·17 cites·28 claims
- 0897USRE45324EIntermediates for the preparation of analogs of halichondrin BAUSTAD BRIAN·Filed 2005·Granted Jan 6, 2015·44 cites·25 claims
- 0997US8445701B2Intermediates for the preparation of analogs of halichondrin BAUSTAD BRIAN·Filed 2012·Granted May 21, 2013·54 cites·6 claims
- 1096US9238672B2Methods for stereoselective reductionINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·14 cites·24 claims
- 1195US10406139B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·8 cites·5 claims
- 1294US9492435B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 15, 2016·13 cites·15 claims
- 1394US8785635B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Jul 22, 2014·16 cites·38 claims
- 1494US8716479B2Methods for stereoselective reductionAUSTAD BRIAN C·Filed 2008·Granted May 6, 2014·19 cites·16 claims
- 1594US8669365B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Mar 11, 2014·21 cites·25 claims
- 1693US12371420B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·14 claims
- 1792US9394313B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jul 19, 2016·12 cites·24 claims
- 1892US9376447B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jun 28, 2016·12 cites·19 claims
- 1991USRE47797EIntermediates for the preparation of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2018·Granted Jan 7, 2020·7 cites·15 claims
- 2091USRE46965EIntermediates for the preparation of analogs of Halichondrin BEISAI R&D MAN CO LTD·Filed 2005·Granted Jul 24, 2018·12 cites·20 claims
- 2190US11007181B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·1 cites·2 claims
- 2290US9951083B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·4 cites·19 claims
- 2390US9879025B2Transfer hydrogenation of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·13 claims
- 2490US8703448B2Enzymatic transamination of cyclopamine analogsAUSTAD BRIAN C·Filed 2011·Granted Apr 22, 2014·19 cites·37 claims
- 2583US9879293B2Enzymatic transamination of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·30 claims
- 2681US7947670B2Ansamycin formulations and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·3 cites·20 claims
- 2765US8357676B2Ansamycin formulations and methods of use thereofINFINITY DISCOVERY INC·Filed 2008·Granted Jan 22, 2013·0 cites·22 claims
- 2865US8283343B2Ansamycin formulations and methods of use thereofAUSTAD BRIAN C·Filed 2008·Granted Oct 9, 2012·0 cites·13 claims
- 2960US2014371456A1Enzymatic Transamination of Cyclopamine AnalogsAUSTAD BRIAN C·Filed 2014·Application pending·0 cites
- 3058US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3158US2012029213A1Intermediates for the preparation of analogs of halichondrin bAUSTAD BRIAN·Filed 2011·Application pending·0 cites
- 3254US12479806B2Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 3354US2018244700A1Methods of treating a fatty acid amide hydrolase-mediated conditionINFINITY PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3452US9034849B2Fatty acid amide hydrolase inhibitorsAUSTAD BRIAN C·Filed 2011·Granted May 19, 2015·0 cites·29 claims
- 3550US9951089B2Methods of treating a fatty acid amide hydrolase-mediated conditionINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Apr 24, 2018·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →